(Circulation. 1998;98:2796-2799.)
© 1998 American Heart Association, Inc.
Brief Rapid Communications |
Prospective Study of Herpes Simplex Virus, Cytomegalovirus, and the Risk of Future Myocardial Infarction and Stroke
From the Divisions of Preventive Medicine (P.M.R., C.H.H.), Cardiovascular Diseases (P.M.R.), Infectious Diseases (F.W.), and the Channing Laboratory (M.J.S.), Department of Medicine, Brigham and Women's Hospital; the Department of Ambulatory Care and Prevention (C.H.H.), Harvard Medical School; and the Departments of Epidemiology (C.H.H., M.J.S.) and Nutrition (M.J.S.), Harvard School of Public Health, Boston, Mass.
Correspondence to Paul M. Ridker, Brigham and Women's Hospital, 900 Commonwealth Ave E, Boston, MA 02115. E-mail pmridker{at}bics.bwh.harvard.edu
Background—It has been hypothesized that infection with either herpes simplex virus (HSV) or cytomegalovirus (CMV) is associated with atherogenesis. However, prospective data relating evidence of prior exposure to these agents with risks of future myocardial infarction (MI) and stroke are sparse.
Methods and Results—In a prospective, nested case-control study of apparently healthy men, the baseline prevalence of antibodies directed against HSV or CMV was similar among 643 men who subsequently developed a first MI or thromboembolic stroke and among 643 age- and smoking-matched men who remained free of reported vascular disease over a 12-year follow-up period. Specifically, the relative risks for future MI and stroke were 0.94 (95% CI, 0.7 to 1.2) for HSV seropositivity and 0.72 (95% CI, 0.6 to 0.9) for CMV seropositivity, after adjustment for other cardiovascular risk factors. These findings were not materially altered in comparisons of early versus late events or in analyses stratified by smoking status. There was no evidence of association between HSV or CMV antibodies and plasma concentration of C-reactive protein, a marker of inflammation that predicts vascular risk in this cohort.
Conclusions—Among apparently healthy middle-aged men, IgG antibodies directed against HSV or CMV do not appear to be a marker for increased atherothrombotic risk. The observed possible inverse relationship of CMV with MI and stroke was unexpected and may well be due to chance, because the direction of association is not compatible with the a priori hypothesis based on proposed biological mechanisms or previous cross-sectional and retrospective data.
Key Words: infection • atherosclerosis • viruses • myocardial infarction • stroke
This article has been cited by other articles:
 |
|
 |
|
  J. Sung, Y.-M. Song, Y.-H. Choi, S. Ebrahim, and G. Davey Smith Hepatitis B Virus Seropositivity and the Risk of Stroke and Myocardial Infarction Stroke, May 1, 2007; 38(5): 1436 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Sheehan, P M Kearney, S O Sullivan, C Mongan, E Kelly, and I J Perry Acute coronary syndrome and chronic infection in the Cork coronary care case-control study Heart, January 1, 2005; 91(1): 19 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Kaski, P. Khairy, S. Rinfret, J.-C. Tardif, R. Marchand, S. Shapiro, J. Brophy, and J. Dupuis Infection, Endothelial Dysfunction, and Atherogenesis * Response Circulation, December 23, 2003; 108 (25): e171 - e172. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Lindsberg and A. J. Grau Inflammation and Infections as Risk Factors for Ischemic Stroke Stroke, October 1, 2003; 34(10): 2518 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Grahame-Clarke, N. N. Chan, D. Andrew, G. L. Ridgway, D. J. Betteridge, V. Emery, H. M. Colhoun, and P. Vallance Human Cytomegalovirus Seropositivity Is Associated With Impaired Vascular Function Circulation, August 12, 2003; 108(6): 678 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Khairy, S. Rinfret, J.-C. Tardif, R. Marchand, S. Shapiro, J. Brophy, and J. Dupuis Absence of Association Between Infectious Agents and Endothelial Function in Healthy Young Men Circulation, April 22, 2003; 107(15): 1966 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. van der Ven, R. van Diest, K. Hamulyak, M. Maes, C. Bruggeman, and A. Appels Herpes Viruses, Cytokines, and Altered Hemostasis in Vital Exhaustion Psychosom Med, March 1, 2003; 65(2): 194 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Espinola-Klein, H.-J. Rupprecht, S. Blankenberg, C. Bickel, H. Kopp, A. Victor, G. Hafner, W. Prellwitz, W. Schlumberger, and J. Meyer Impact of Infectious Burden on Progression of Carotid Atherosclerosis Stroke, November 1, 2002; 33(11): 2581 - 2586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Haider, P. W. F. Wilson, M. G. Larson, J. C. Evans, E. L. Michelson, P. A. Wolf, C. J. O'Donnell, and D. Levy The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: A prospective study J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1408 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Prasad, J. Zhu, J. P.J. Halcox, M. A. Waclawiw, S. E. Epstein, and A. A. Quyyumi Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction Circulation, July 9, 2002; 106(2): 184 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Auer, R. Berent, T. Weber, and B. Eber Cytokine gene polymorphisms and development of CAD associated with CP infection J. Am. Coll. Cardiol., March 6, 2002; 39(5): 918 - 919. [Full Text] [PDF]
|
|
|
|
|
|
P. Lavallee, V. Perchaud, M. Gautier-Bertrand, D. Grabli, and P. Amarenco Association Between Influenza Vaccination and Reduced Risk of Brain Infarction Stroke, February 1, 2002; 33(2): 513 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Espinola-Klein, H. J. Rupprecht, S. Blankenberg, C. Bickel, H. Kopp, G. Rippin, A. Victor, G. Hafner, W. Schlumberger, and J. Meyer Impact of Infectious Burden on Extent and Long-Term Prognosis of Atherosclerosis Circulation, January 1, 2002; 105(1): 15 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-J. Neumann, A. Kastrati, T. Miethke, J. Mehilli, G. Pogatsa-Murray, W. Koch, M. Seyfarth, and A. Schomig Previous Cytomegalovirus Infection and Restenosis After Coronary Stent Placement Circulation, September 4, 2001; 104(10): 1135 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Rupprecht, S. Blankenberg, C. Bickel, G. Rippin, G. Hafner, W. Prellwitz, W. Schlumberger, and J. Meyer Impact of Viral and Bacterial Infectious Burden on Long-Term Prognosis in Patients With Coronary Artery Disease Circulation, July 3, 2001; 104(1): 25 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Blankenberg, H. J. Rupprecht, C. Bickel, C. Espinola-Klein, G. Rippin, G. Hafner, M. Ossendorf, K. Steinhagen, and J. Meyer Cytomegalovirus Infection With Interleukin-6 Response Predicts Cardiac Mortality in Patients With Coronary Artery Disease Circulation, June 19, 2001; 103(24): 2915 - 2921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al. Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association Circulation, January 2, 2001; 103(1): 163 - 182. [Full Text] [PDF]
|
|
|
|
|
|
L. B. Goldstein, R. Adams, K. Becker, C. D. Furberg, P. B. Gorelick, G. Hademenos, M. Hill, G. Howard, V. J. Howard, B. Jacobs, et al. Primary Prevention of Ischemic Stroke : A Statement for Healthcare Professionals From the Stroke Council of the American Heart Association Stroke, January 1, 2001; 32(1): 280 - 299. [Full Text] [PDF]
|
|
|
|
|
|
D. S. Siscovick, S. M. Schwartz, L. Corey, J. T. Grayston, R. Ashley, S.-P. Wang, B. M. Psaty, R. P. Tracy, L. H. Kuller, and R. A. Kronmal Chlamydia pneumoniae, Herpes Simplex Virus Type 1, and Cytomegalovirus and Incident Myocardial Infarction and Coronary Heart Disease Death in Older Adults : The Cardiovascular Health Study Circulation, November 7, 2000; 102(19): 2335 - 2340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Muhlestein, B. D. Horne, J. F. Carlquist, T. E. Madsen, T. L. Bair, R. R. Pearson, and J. L. Anderson Cytomegalovirus Seropositivity and C-Reactive Protein Have Independent and Combined Predictive Value for Mortality in Patients With Angiographically Demonstrated Coronary Artery Disease Circulation, October 17, 2000; 102(16): 1917 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Espinola-Klein, H.-J. Rupprecht, S. Blankenberg, C. Bickel, H. Kopp, G. Rippin, G. Hafner, U. Pfeifer, and J. Meyer Are Morphological or Functional Changes in the Carotid Artery Wall Associated With Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus, or Herpes Simplex Virus Infection? Stroke, September 1, 2000; 31(9): 2127 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Koh Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability Cardiovasc Res, September 1, 2000; 47(4): 648 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Alber, K. L. Powell, P. Vallance, D. A. Goodwin, and C. Grahame-Clarke Herpesvirus Infection Accelerates Atherosclerosis in the Apolipoprotein E-Deficient Mouse Circulation, August 15, 2000; 102(7): 779 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. W. Fong Emerging relations between infectious diseases and coronary artery disease and atherosclerosis Can. Med. Assoc. J., July 1, 2000; 163(1): 49 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Kirkham, M. Prengler, D. K.M. Hewes, and V. Ganesan Risk Factors for Arterial Ischemic Stroke in Children J Child Neurol, May 1, 2000; 15(5): 299 - 307. [Abstract] [PDF]
|
|
|
|
|
|
P. M. Ridker, N. Rifai, M. J. Stampfer, and C. H. Hennekens Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men Circulation, April 18, 2000; 101(15): 1767 - 1772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Roivainen, M. Viik-Kajander, T. Palosuo, P. Toivanen, M. Leinonen, P. Saikku, L. Tenkanen, V. Manninen, T. Hovi, and M. Manttari Infections, Inflammation, and the Risk of Coronary Heart Disease Circulation, January 25, 2000; 101(3): 252 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Blum Anti-CMV Antibodies and Coronary Artery Disease Circulation, December 21, 1999; 100 (25): e138 - e138. [Full Text] [PDF]
|
|
|
|
|
|
F. J. Nieto, M. Szklo, P. D. Sorlie, P. M. Ridker, C. H. Hennekens, M. J. Stampfer, and F. Wang Cytomegalovirus Infection and Coronary Heart Disease • Response Circulation, December 21, 1999; 100 (25): e139 - e139. [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Haider, M. Luna, S. Patel, J. M. Gaziano, L. Glenn, L. M. Golub, R. A. Greenwald, R. W. Thompson, D. L. Hahn, M. R. Hammerschlag, et al. Antibiotic Use and Risk of Myocardial Infarction JAMA, December 1, 1999; 282(21): 1997 - 1999. [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Ridker, C. H. Hennekens, J. E. Buring, R. Kundsin, and J. Shih Baseline IgG Antibody Titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes Simplex Virus, and Cytomegalovirus and the Risk for Cardiovascular Disease in Women Ann Intern Med, October 19, 1999; 131(8): 573 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Epstein and J. Zhu Lack of Association of Infectious Agents With Risk of Future Myocardial Infarction and Stroke : Definitive Evidence Disproving the Infection/Coronary Artery Disease Hypothesis? Circulation, September 28, 1999; 100(13): 1366 - 1368. [Full Text] [PDF]
|
|
|
|
|
|
M. R. DO, T.-P. Tuomainen, K. Nyyssonen, J. T. Salonen, and K. Punnonen Body Iron Stores, Infection, and Risk of Acute Myocardial Infarction • Response Circulation, July 27, 1999; 100(4): 446 - 449. [Full Text] [PDF]
|
|
|
|
|
|
S. E. Epstein, Y. F. Zhou, and J. Zhu Infection and Atherosclerosis : Emerging Mechanistic Paradigms Circulation, July 27, 1999; 100 (4): e20 - e28. [Abstract] [Full Text] [PDF]
|
|